Cargando…
Bracteanolide A abrogates oxidative stress‐induced cellular damage and protects against hepatic ischemia and reperfusion injury in rats
Liver diseases, including viral hepatitis, liver cirrhosis, and liver cancer, mostly remain silent until the late stages and pose a continuing threat to millions of people worldwide. Liver transplantation is the most appropriate solution in the case of liver failure, but it is associated with hepati...
Autores principales: | Chao, Ting‐Yu, Hsieh, Cheng‐Chu, Kuo, Yueh‐Hsiung, Yu, Ya‐Ju, Wan, Cho‐Hua, Hsieh, Shu‐Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441430/ https://www.ncbi.nlm.nih.gov/pubmed/34531989 http://dx.doi.org/10.1002/fsn3.2374 |
Ejemplares similares
-
Abrogation of graft ischemia‐reperfusion injury in ischemia‐free liver transplantation
por: Guo, Zhiyong, et al.
Publicado: (2022) -
Preconditioning somatothermal stimulation on Qimen (LR14) reduces hepatic ischemia/reperfusion injury in rats
por: Hsieh, Cheng-Chu, et al.
Publicado: (2014) -
Protective Effects of N-acetylcysteine and a Prostaglandin E1 Analog, Alprostadil, Against Hepatic Ischemia: Reperfusion Injury in Rats
por: Hsieh, Cheng-Chu, et al.
Publicado: (2014) -
Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusion
por: Binsch, C., et al.
Publicado: (2023) -
Pyrrolidinyl caffeamide against ischemia/reperfusion injury in cardiomyocytes through AMPK/AKT pathways
por: Lee, Shih-Yi, et al.
Publicado: (2015)